What is a clinical trial and why it matters
Fate Therapeutics is currently recruiting patients living with either certain autoimmune diseases or cancer types for CAR T-cell therapy trials.
For additional information or to inquire about participating in any of Fate’s clinical trials please contact: clinicaltrials@fatetherapeutics.com or download our patient brochure
Patient Journeys
Experience what participating in a CAR T-cell therapy clinical trial for Lupus may be like for you
FT819-201 RECLAIM-LN Study
Condition: Lupus Nephritis
This is a Phase 2 single-arm trial designed to evaluate the efficacy and safety of FT819 in participants with moderate-to-severe systemic lupus erythematosus (SLE) with Class III/IV lupus nephritis (LN) (with or without concomitant Class V involvement) refractory to at least 2 immunosuppressive therapies prior to trial intervention.
Participation Expectations




